anti-CD19 CAR-T
20170316
Phase 1 mab active
Quick answer
anti-CD19 CAR-T for B-cell Adult Acute Lymphoblastic Leukemia is a Phase 1 program (mab) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- B-cell Adult Acute Lymphoblastic Leukemia
- Phase
- Phase 1
- Modality
- mab
- Status
- active